Literature DB >> 15744582

Amino acid variation within the fusion protein of respiratory syncytial virus subtype A and B strains during annual epidemics in South Africa.

Elizabeth Agenbach1, Caroline T Tiemessen, Marietjie Venter.   

Abstract

Recent evidence of positive selection within the cytotoxic T-cell (CTL) epitopes of the highly conserved nucleoprotein of influenza virus raised the question of whether the CTL epitopes of Respiratory syncytial virus (RSV) are also affected by immune driven change over annual epidemics. The fusion protein (F-protein) of RSV is highly conserved within the two subtypes (A and B) and the most important target for the protective response. The position of various neutralizing epitopes has been mapped and characterized between RSV subtypes. CTL epitopes have also recently been mapped for the F-protein of subtype A, however variation within these epitopes between and within the subtypes has not been determined. To address this question, the F-proteins of 18 strains representative of all subgroup A and B genotypes identified in South Africa over a period of 5 years were sequenced. F-protein sequences were highly conserved within and between South African genotypes, with most variability occurring at the nucleotide level. Most of the amino acid differences identified within neutralizing and CTL epitopes were conserved within the subtypes, and therefore does not indicate immune selection. However, out of three CTL epitopes previously identified in subtype A, two (restricted to HLA B*57 and HLA A *01) were conserved only within subtype A, while the third (restricted to Cw*12) contained both subtype- and genotype-specific changes. These results suggest that most of the identified CTL epitopes are subtype A-specific and may not be recognized in subtype B viruses, while the HLA Cw*12 restricted epitope may also not be recognized efficiently in GA5 strains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744582     DOI: 10.1007/s11262-004-5633-2

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  59 in total

1.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Cross-reactive and group-specific immune responses to a neutralizing epitope of the human respiratory syncytial virus fusion protein.

Authors:  C Corvaisier; C Bourgeois; P Pothier
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

3.  Improvements in protein secondary structure prediction by an enhanced neural network.

Authors:  D G Kneller; F E Cohen; R Langridge
Journal:  J Mol Biol       Date:  1990-07-05       Impact factor: 5.469

4.  Antigenic structure of human respiratory syncytial virus fusion glycoprotein.

Authors:  J A López; R Bustos; C Orvell; M Berois; J Arbiza; B García-Barreno; J A Melero
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

5.  A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.

Authors:  H Takahashi; S Merli; S D Putney; R Houghten; B Moss; R N Germain; J A Berzofsky
Journal:  Science       Date:  1989-10-06       Impact factor: 47.728

6.  Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.

Authors:  B García-Barreno; C Palomo; C Peñas; T Delgado; P Perez-Breña; J A Melero
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: Comparison of viruses and genotypes responsible for different disease manifestations.

Authors:  M Venter; M Collinson; B D Schoub
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

9.  Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.

Authors:  P R Johnson; R A Olmsted; G A Prince; B R Murphy; D W Alling; E E Walsh; P L Collins
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

10.  Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains.

Authors:  Marietjie Venter; Michael Rock; Adrian J Puren; Caroline T Tiemessen; James E Crowe
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  11 in total

1.  An Epitope-Specific Respiratory Syncytial Virus Vaccine Based on an Antibody Scaffold.

Authors:  Xiaozhou Luo; Tao Liu; Ying Wang; Haiqun Jia; Yuhan Zhang; Dawna Caballero; Juanjuan Du; Rongsheng E Wang; Danling Wang; Peter G Schultz; Feng Wang
Journal:  Angew Chem Int Ed Engl       Date:  2015-10-05       Impact factor: 15.336

2.  Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.

Authors:  Kate L Stokes; Michael H Chi; Kaori Sakamoto; Dawn C Newcomb; Michael G Currier; Matthew M Huckabee; Sujin Lee; Kasia Goleniewska; Carla Pretto; John V Williams; Anne Hotard; Taylor P Sherrill; R Stokes Peebles; Martin L Moore
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

3.  Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.

Authors:  Hsiao-Yun Shao; Yi-Wen Lin; Shu-Ling Yu; Hsiang-Yin Lin; Ebenezer Chitra; Yung-Chen Chang; Charles Sia; Pele Chong; Ming-Tao Hsu; Olivia L Wei; Yen-Hung Chow
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

4.  Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected children.

Authors:  Rajni Kumaria; Laxmi Ravi Iyer; Martin L Hibberd; Eric A F Simões; Richard J Sugrue
Journal:  Virol J       Date:  2011-07-28       Impact factor: 4.099

5.  Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing.

Authors:  Kelly Huang; Heather Lawlor; Roderick Tang; Randall S MacGill; Nancy D Ulbrandt; Herren Wu
Journal:  Virus Genes       Date:  2010-01-29       Impact factor: 2.198

6.  Sequencing and analysis of globally obtained human respiratory syncytial virus A and B genomes.

Authors:  Michael E Bose; Jie He; Susmita Shrivastava; Martha I Nelson; Jayati Bera; Rebecca A Halpin; Christopher D Town; Hernan A Lorenzi; Daniel E Noyola; Valeria Falcone; Giuseppe Gerna; Hans De Beenhouwer; Cristina Videla; Tuckweng Kok; Marietjie Venter; John V Williams; Kelly J Henrickson
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.

Authors:  Anne M Hause; David M Henke; Vasanthi Avadhanula; Chad A Shaw; Lorena I Tapia; Pedro A Piedra
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

8.  Molecular epidemiology and phylodynamics of the human respiratory syncytial virus fusion protein in northern Taiwan.

Authors:  Hsin Chi; Hsin-Fu Liu; Li-Chuan Weng; Nai-Yu Wang; Nan-Chang Chiu; Mei-Ju Lai; Yung-Cheng Lin; Yu-Ying Chiu; Wen-Shyang Hsieh; Li-Min Huang
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

9.  Gene sequence variability of the three surface proteins of human respiratory syncytial virus (HRSV) in Texas.

Authors:  Lorena I Tapia; Chad A Shaw; Letisha O Aideyan; Alan M Jewell; Brian C Dawson; Taha R Haq; Pedro A Piedra
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  Molecular Characterization of Respiratory Syncytial Virus in Children With Repeated Infections With Subgroup B in the Philippines.

Authors:  Michiko Okamoto; Clyde P Dapat; Ann Marie D Sandagon; Leilanie P Batangan-Nacion; Irene C Lirio; Raita Tamaki; Mayuko Saito; Mariko Saito-Obata; Socorro P Lupisan; Hitoshi Oshitani
Journal:  J Infect Dis       Date:  2018-08-24       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.